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Cardiac resynchronization therapy (CRT) improves symptoms and cardiac function in
patients with heart failure and prolongs QRS duration on an electrocardiogram. However,
additional eﬀects of concomitant CRT in patients who undergo cardiac surgery are unclear.
We assessed the clinical eﬃcacy of this therapy when it is performed concomitantly with
primary cardiac surgery.
METHODS: We evaluated four patients who underwent primary surgery and CRT between
February 2002 and December 2003, and compare clinical data with four patients who
underwent conventional primary surgery without CRT.
RESULTS: Primary surgeries were CABG (n ¼ 2), aortic valve replacement (n ¼ 1),
mitral valve plasty (n ¼ 1) and mitral annular plication (n ¼ 4). After the operation,
symptoms associated with congestive heart failure were improved in all patients. The average
NYHA class improvement was from 3:3 0:5 before the operation to 1:7 0:6 after the
operation. All patients were discharged after surgery. Only one patient needed re-hospital-
ization for congestive heart failure one month after the operation. The mean QRS duration
(190 47:6ms vs 160 16:3ms), cardiothoracic ratio (60:7 5:7% vs 58:5 2:9%) and
ejection fraction (28:5 8:8% vs 50:0 0:0%) were also improved after surgery.
CONCLUSION: In patients with poor left ventricular function and impaired cardiac
conduction, CRT performed concomitantly with primary surgery may improve the post-
operative course. Further study on indications for implantation of a CRT device during
primary surgery is needed.
(J Arrhythmia 2005; 21: 523–527)
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Introduction
Since the introduction of angiotensin-converting
enzyme (ACE) inhibitors and beta-blockers in the
treatment of heart failure due to left ventricle (LV)
systolic dysfunction, pharmacological therapy for
patients with heart failure has made remarkable
progress. However, the prognosis of patients with
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severe heart failure remains poor. The beneﬁt of
medical treatment is probably short-lived, merely
delaying the inevitable progression to heart failure
that is refractory to drug treatment.3)
A subset of patients with severe systolic heart
failure have a prolonged QRS duration, which
several studies have suggested as an independent
risk factor for adverse outcome in patients with heart
failure due to LV systolic dysfunction.6) Cardiac
resynchronization therapy (CRT), which can coor-
dinate asynchronous motion of the LV and reduce
mechanical mitral regurgitation, has been shown to
improve symptoms, quality of life, and exercise
capacity of patients with severe heart failure.2) CRT
has the possibility to become a useful optional
strategy for patients with severe heart failure and
prolonged QRS duration. Moreover, the CRT may be
beneﬁcial as additional therapy in patients receiving
cardiac surgery due to heart failure. The aim of this
study was to elucidate the eﬀect of CRT when it is
performed concomitantly with primary cardiac sur-
gery.
Methods
1) Subjects
Four patients with New York Heart Association
class III or IV heart failure due to LV systolic
dysfunction (ejection fraction < 35% assessed by
echocardiography or left ventriculography) and a
duration of the QRS interval of more than 120ms
were evaluated.
The characteristics of the patients are summarized
in Table 1. All patients had shortness of breath and
limitation of activities of daily life in spite of optimal
medical treatment including diuretics and ACE
inhibitors. DDD pacemakers had been implanted
for complete AV block in three patients before
primary cardiac surgery. Implantation of a pace-
maker was planned for another patient who had sick
sinus syndrome. All patients underwent primary
cardiac surgery, including coronary-aorto bypass
graft, aortic valve replacement, mitral valve plasty
and mitral annular plication, and also underwent
concomitant CRT between February 2002 and
December 2003. Control group consisted of four
patients (mean age 68:7 8:5 years) with New York
Heart Assosiation class III or IV due to LV systolic
Table 1 Patient characteristics.
Case Age Diagnosis Pacemaker implantationbefore operation Operation
Operation time
(hours)
Hospitalization
after operation
(days)
1 male 61 OMI (Anterior), SSS,Chronic renal failure on HD No CABG (Ao-D1-LAD), MAP 4.5 23
2 female 60 d-HCM, AR, MR,Complete AV block DDD AVR (CM21 mm), MAP 7.5 22
3 male 68 Unstable AP, OMI,Complete AV block DDD
Emergent CABG
(LITA-LAD, Ao-RCA-LCx)
MAP
6 23
4 female 72 DCM, MR, Complete AV block DDD MVP, MAP 5 29
MI = myocardial infarction, HCM = hypertrophic cardiamyopathy, AR = aortic regurgitation, DCM = dilated cardiomyopathy,
CABG = coronary-aortic bypass graft, MAP = mitral annular plication, AVR = aortic valve replacement, MVP = mitral valve
plasty
Table 2 Patient characteristics of control group.
Case Age Diagnosis Operation Operation time(hours)
Hospitalization
after operation
(days)
1 male 62 OMI (Inferior), MR CABGMAP 7.3 21
2 female 78 AS, PH AVR 6 30
3 male 61 Old MI (Anterior) CABGMAP 3.5 20
4 male 74 Unstable angina MVP, MAP 3.8 37
AS = aortic stenosis, PH = pulmonary hypertension
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dysfunction (ejection fraction < 35% assessed by
echocardiography or left ventriculography) who
underwent conventional primary surgery without
CRT. Primary surgeries were CABG (n ¼ 3), aortic
valve replacement (n ¼ 1) and mitral annular plica-
tion (n ¼ 1). (Table 2)
2) Implantation of a biventricular pacemaker
In all cases, epicardial leads were used for LV
pacing with the lead tip placed in the LV lateral wall.
The atrial lead was placed high in the right atrium,
and the right ventricular (RV) lead was placed at the
apex. In patients who had undergone DDD pace-
maker implantation, an intravenous lead for DDD
pacing was used for CRT. VIRTUS PLUS II DR
1480 (Guidant, Minnesota, USA) was used in all
subjects with LV and RV leads connected to the
ventricular port of the pacemaker by a 2-in-1
connector. Optimal AV delay was determined
individually after the operation by coordination of
LV wall motion and LV inﬂow pattern on an
echocardiogram.
3) Follow-up
At baseline (before the primary operation), soon
after the primary operation and at the end of the
follow-up period, patients were evaluated according
to NYHA classiﬁcation, need for hospitalization, and
result of 12-lead electrocardiography, chest radiog-
raphy and echocardiography. LV dimensions were
measured by M-mode echocardiography in the
parasternal long axis view. LV ejection fraction
was quantiﬁed by Simpson’s method or by left
ventriculography.
Results
1) Initial clinical courses
The implantation of the device was successful and
scheduled primary operations of all case were
performed uneventfully. There was no complication
related to implantation of CRT devices. Operation
time was a little longer than that of conventional
primary operation without CRT (Table 1). (Mean
operation time: 5.7 hours vs 5.2 hours).
Postoperative course of patients 1, 2 and 3 were
uneventful. Only one patient (patient 4) suﬀered
from persistent congestive heart failure due to
sensing failure of the atrial lead. After adjustment
of the pacemaker program, the patient’s congestive
heart failure improved and the postoperative course
after that was satisfactory. After the operation,
symptoms of all patients associated with congestive
heart failure improved. The average of NYHA class
improved from 3:3 0:5 before the operation to
1:7 0:6 after the operation (Figure 1). Mean hospi-
talization period after operation was shorter than that
of control group (24.3 days vs 28.8 days). All
patients were discharged after surgery. However, one
patient (patient 1) needed re-hospitalization for
congestive heart failure one month after the oper-
ation because of worsening of mitral regurgitation.
The other three patients did not need hospitalization
after discharge and are doing well without special
limitations on their daily life.
2) Follow-up
CRT reduced the mean QRS duration from 190
47:6ms before operation to 160 16:3ms after the
operation (Figure 2). However, one patient (patient 1)
showed no signiﬁcant change in QRS duration after
the operation.
The cardiothoratic ratio (CTR) decreased slightly
during a period of 15.2 months after the operation
(60:7 5:7% vs 58:5 2:9%). CTR in patient 1,
who had recurrence of congestive heart failure after
discharge, was higher than that before the operation.
Results of echocardiographic study are shown in
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Figure 1 NYHA classiﬁcations before and after surgery.
NYHA classiﬁcation improved in all patients after the operation.
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Figure 2 QRS durations before and after surgery.
QRS duration improved in all but one of the patients.
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Table 3. The postoperative ejection fraction (EF) had
a tendency to improve after the operation (28:5
8:8% vs 50:0 0:0%), and LV wall motion, espe-
cially that of the ventricular septum and lateral wall,
was more symmetrical than that before the operation
in all cases.
The average of end-diastolic dimension of LV also
had a tendency to improve, from 60:5 12:8mm to
55:5 12:2mm.
Discussion
Both CRT and primary surgery are shown to
improve symptoms and cardiac function in patients
with heart failure. The distinctive point of this study
was to elucidate the eﬀect of CRT and primary
cardiac surgery when they are performed simulta-
neously. In this study, the addition of CRT improved
heart failure status and LV systolic function.
The mechanisms by which CRT improves me-
chanical LV function in patients with asynchronous
wall motion are not completely understood. Elec-
trical resynchronization can reduce mechanical
interventricular dyssynchrony between the right
and the left ventricles and intraventricular dyssyn-
chrony within the left ventricle. Minimizing intra-
ventricular dyssynchrony has been shown to improve
global EF function. CRT has been shown to increase
LV ﬁlling time, decrease septal dyskinesis and
reduce mitral regurgitation, thus improving hemody-
namics.1) Many studies have shown that both CRT
and LV pacing may reduce the degree of asynchro-
nous wall motion of the LV in patients with
intraventricular conduction delay. CRT has also
been shown to increase systolic blood pressure and
reduce PCWP and MR.
A recent randomized trial showed that CRT
signiﬁcantly improves exercise tolerance and quality
of life.12) Moreover, CRT reduced measures of
morbidity and mortality in several studies.1) CRT
has become a useful strategy for patients with severe
LV systolic dysfunction and CLBBB.
It is possible that CRT supports the postoperative
course of patients who have undergone cardiac
surgery and improves quality of life and reduces
mortality rate. CRT probably has less potential to
improve symptoms of heart failure than other
primary surgery modalities because it is not a
therapy to promote contractibility but to coordinate
asynchronous wall motion. The postoperative course
of patients is therefore thought to be inﬂuenced
much more by the primary surgery than by CRT.
However, for patients with severe LV systolic
dysfunction, a small hemodynamic change may have
a big inﬂuence on their symptoms. Hemodynamic
change induced by CRT, even if it is not so great,
can improve the postoperative course of patients
with heart failure. Therefore, concomintant CRT
should be considered as an additional therapy for
patients with LV systolic dysfunction who are
scheduled to undergo primary surgery.
Conclusion
CRT performed concomitantly with primary sur-
gery may improve the postoperative course of
patients with poor LV function and impaired cardiac
conduction. For patients who have undergone pace-
maker implantation, upgrading pacemaker to CRT is
a good optional strategy of primary surgery with
thoracotomy. Further study on indications for im-
plantation of a CRT device during primary surgery is
needed.
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